secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anika Therapeutics, Inc. (ANIK)
CIK:        0000898437
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0001171843-23-005813
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anika Therapeutics files investor presentation with pipeline updates; no financial details provided
--------------------------------------------------------------------------------

- Presentation for Sidoti Small Cap Conference dated September 21, 2023, furnished as Exhibit 99.1.
- Slide deck covers corporate updates, product portfolio, and pipeline, but attached exhibit contains only title slide.
- No specific revenue, profit, guidance, or clinical data disclosed in the filing or exhibit provided.
- Company refers to its website for full presentation; this filing is procedural under Item 7.01.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/898437/000117184323005813/0001171843-23-005813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/898437/000117184323005813/f8k_092123.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-005813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer